Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
RRT and Intoxications Timothy E Bunchman Case Study-1 17 y/o female with poly pharmacy overdose including risperidone, stratttera and long acting Lithium She is not on any medications chronically 12 hours post overdose she is semi comatose with QT interval changes on EKG Case Study-2 There is no hepatic nor renal dysfunction Lithium level was > 5.1 mmol/l (critical > 4) Thought Process of RRT in Intoxication Is the drug long or short acting Is there any inhibition of the natural excretion of the drug What is the molecular weight? What is the protein binding? Is this single or double compartment? INTRODUCTION • • • 2.2 million reported poisonings (1998) 67% in pediatrics Approximately 0.05% required extracorporeal elimination Primary prevention strategies for acute ingestions have been designed and implemented (primarily with legislative effort) with a subsequent decrease in poisoning fatalities PHARMOCOKINETIC COMPARTMENTS ELIMINATION I N P U T Distribution Re-distribution kidney blood Peripheral liver GI Tract GENERAL PRINCIPLES kinetics of drugs are based on therapeutic not toxic levels (therefore kinetics may change) choice of extracorporeal modality is based on availability, expertise of people & the properties of the intoxicant in general Each Modality has drawbacks It may be necessary to switch modalities during therapy (combined therapies inc: endogenous excretion/detoxification methods) INDICATIONS >48 hrs on vent ARF Impaired metabolism high probability of significant morbidity/mortality progressive clinical deterioration INDICATIONS severe intoxication with abnormal vital signs complications of coma prolonged coma intoxication with an extractable drug HEMODIALYSIS optimal drug characteristics for removal: relative molecular mass < 500 water soluble small Vd (< 1 L/Kg) minimal plasma protein binding single compartment kinetics low endogenous clearance (< 4ml/Kg/min) (Pond, SM - Med J Australia 1991; 154: 617-622) Intoxicants amenable to Hemodialysis vancomycin (high flux) alcohols diethylene glycol methanol lithium salicylates Ethylene Glycol Intoxication Rx with Hemodialysis 900 800 700 600 500 Pt 1 Pt 2 400 300 200 100 0 0 2 4 Duration of Rx (hrs) 6 Vancomycin clearance High efficiency dialysis membrane 250 Rx Rx Rx 200 Rebound Rebound 150 Pt 1 Pt 2 100 50 0 0 3 12 15 Time of therapy 27 30 High flux hemodialysis for Carbamazine Intoxication Rx 35 30 Mic/ml 25 20 CBZ level (nl < 12) 15 10 5 0 0 5 10 15 20 25 30 Hrs from time of ingestion 35 40 HEMOFILTRATION optimal drug characteristics for removal: relative molecular mass less than the cut-off of the filter fibres (usually < 40,000) small Vd (< 1 L/Kg) single compartment kinetics low endogenous clearance (< 4ml/Kg/min) (Pond, SM - Med J Australia 1991; 154: 617-622) Hemofiltration Can be combined with acute high flux HD Indicated in cases where removal of plasma toxin is then replaced by redistributed toxin from tissue Solute Molecular Weight and Clearance Solute (MW) Sieving Coefficient Diffusion Coefficient Urea (60) 1.01 ± 0.05 1.01 ± 0.07 Creatinine (113) 1.00 ± 0.09 1.01 ± 0.06 Uric Acid (168) 1.01 ± 0.04 0.97 ± 0.04* Vancomycin (1448) 0.84 ± 0.10 0.74 ± 0.04** *P<0.05 vs sieving coefficient **P<0.01 vs sieving coefficient HD to Convective HF High Flux HD 6 5 Lithium mmol/l Li Level 8 liter CVVHDF 4 liter CVVH 4 3 2 liter CVVH 2 1 0 0 1 2 4 6 14 23 27 48 CVVHD following HD for Lithium poisoning L 6 i HD started 5 CVVHD started m 4 E q 3 / 2 L Pt #1 Pt #2 Li Therapeutic range 0.5-1.5 mEq/L CT-190 (HD) Multiflo-60 both patients BFR-pt #1 200 ml/min HD & CVVHD -pt # 2 325 ml/min HD & 200 ml/min CVVHD PO4 Based dialysate at 2L/1.73m2/hr 1 0 Hours 24 12 6 5 0 Intoxicants amenable to Hemofiltration vancomycin methanol procainamide hirudin thallium lithium methotrexate Albumin augmented Diffusive Hemofiltration Serum half-life (hr) Valproic Acid Total Unbound Total Baseline 10.3 CVVHD 7.7 4.5 0.12 CVVHD +Albumin 4.0 3.0 0.32 10.0 SievingCoefficient* Carbamazine Clearance Clearance with Albumin Dialysis Askenazi et al, Pediatrics 2004 Natural Decay Conclusion RRT with the use of high flux hemodialysis and convective hemofiltration may allow for continuous removal of intoxication Attention to single or double compartment kinetics will dertemine the length of time of excretion